Jimmy Lin, PhD
MD/PhD Candidate at Johns Hopkins School of Medicine
Jimmy is the lead computational biologist for the ground-breaking cancer genome sequencing efforts from the Vogelstein Lab at Johns Hopkins. Their sequencing of the first 100+ cancer exomes in 5 different tissue types has helped lay the foundation for a revolution in cancer genomics.
Scott Taing
Bioinformatics Researcher, Harvard School of Public Health
Scott is the data curator for the modENCODE chromatin group through the Lui Lab of the Dana Farber Cancer Institute and Harvard School of Public Health. His interests are developing systems and tools to handle analysis and visualize the genomics dada. He did graduate level work at Johns Hopkins and Nanjing University and holds a bachelor from Yale University.
Imran A. Babar, PhD
Molecular Biology PhD, Yale University
Imran completed his PhD in Molecular Biology in Dr. Frank Slack's lab at Yale University. For his thesis he researched microRNAs as both causes and treatments for cancers using mouse models and human cancer cell lines. While at Yale Imran was a Howard Hughes Fellow, Harvey Fellow, and a fellow for the Lindau Nobel Laureate Meeting for young scholars. Prior to Yale, Imran completed his BA in Biology at Carleton College and conducted research at MIT and NIH.
Daniel Estevez Prado
Biochemist, BMEP Fellow, Yale University
Daniel completed his professional training in computer science, received a B.Sc. in Biochemistry from the University of Technology in Munich, studied Medicinal Chemistry at the Open University, and Structural Molecular Biology at the Birkbeck College, University of London. He joined the Yale School of Medicine as a BMEP fellow in 2009 and will soon start at the King's College London as a postgraduate student in Molecular Biophysics.
Jonathan Franca-Koh, PhD
Staff Scientist at the J. Craig Venter Institute
Jonathan received his BSc and PhD in Cell and Molecular Biology from the University of London. He subsequently joined the laboratory of Peter Devreotes at Johns Hopkins University as a post-doctoral fellow to research cell migration and chemotaxis. He is currently a Staff Scientist at the J. Craig Venter Institute and an MBA student at the Johns Hopkins Carey Business School.
Naira C. Rezende
Ph.D. Candidate at Weill Cornell Graduate School of Medical Sciences
Naira is currently concluding her PhD in Molecular Biology at Weill Cornell, where she studies stem cells. During her tenure at Cornell, Naira was a fellow of the Howard Hughes Medical Institute, and a Science and Technology Policy Fellow at the National Academy of Sciences, where she works with the Committee on Science, Technology and Law.
Michael Lee
MD/JD Candidate, Yale Law School and Washington University School of Medicine
As an MD/JD candidate, Mike is specifically interested in the intersection of medicine and law--and especially in health care finance. Michael wrote his thesis on the Affordable Care Act of 2010, the landmark health reform bill, and has written and spoken publicly on the highly controversial statute. He has also consulted for the Department of Homeland Security on bioterrorism, worked in a law firm on Medicare compliance issues, served as a teaching assistant in statistics and economics, and served as the editor-in-chief of the Yale Journal of Health Policy, Law, and Ethics.
Liew Jun Mun
Junior Doctor, Malaysia Government Hospital
Mun is currently working as a junior doctor for a government hospital in Malaysia. He graduated from Manipal University, India with Bachelors of Medicine and Surgery (MBBS). He has worked as a research assistant in a variety of organizations, including a non-governmental organization working with refugees, the Department of Opthalmology at the CASE Western Reserve School of Medicine, and the Department of Pathology at Johns Hopkins Hospital. At RGI, he is responsible for site development in Malaysia and Singapore.
Sheun Ogunsunlade
Global MBA Candidate, Johns Hopkins University Carey Business School
Sheun is finishing the last year of the Global MBA program at Johns Hopkins, where he concentrates in marketing and entrepreneurship. He is currently working with social media and aspects of generating online presence and reputation. Previously he attended Carnegie Mellon University and studied Biomedical and Chemical engineering during undergrad.
Elvena Fong
Global MBA Candidate, Johns Hopkins University Carey Business School
Elvena received both a BS in Biochemistry with a computer science minor and a MS in Biotechnology with specialization in bioinformatics from Georgetown University. After working in the industry for three years as a bioinformatics developer creating tools and software solutions to aid scientific researchers, she decided to enter business school to gain a better understanding of business.
Ling Zhang
Global MBA Candidate, Johns Hopkins University Carey Business School
Ling Zhang is now a MBA candidate from the Johns Hopkins Carey Business School. Ling has experiences in healthcare and social entrepreneurship, as well as managing business development in new markets. With the passion to explore new social innovation models, Ling once worked for two start-up social enterprises and explored markets in China and India. Ling has broad strengths in strategic planning, introduction of new products, process management and organizational assessment under different contexts.
Romina Ortiz
Molecular Microbiology and Immunology MA Candidate, The Johns Hopkins Bloomberg School of Public Health
Currently in the Master's Program for Molecular Microbiology and Immunology at the Johns Hopkins School of Public Health. Received a Bachelor's in Neuroscience with a concentration in System's Neuroscience from Johns Hopkins University. Conducted research at City of Hope Cancer Research Center in Los Angeles California and Johns Hopkins Hospital.
Claudia Ou-Yang
Ph.D. Candidate at Duke University Medical Center
Claudia is a Ph.D. candidate in Immunology at Duke University, where she studies signal transduction in T cells using mouse models and human cell lines. Prior to Duke, Claudia received her MS in Microbiology/Immunology with specialization in human genetics and pharmacogemonics from National Taiwan University and Academia Sinica.
Rachelle Li
Global MBA Candidate, Johns Hopkins Carey Business School
Rachelle Li is a first year Global MBA student at Johns Hopkins Carey Business School. Previously, she attended Guangdong University of Foreign Studies in China, majoring in Finance and English. She has volunteered for Guangzhou Asian Games Organizing Committee for two years. She also has experience in wealth management, commercial banking and micro-finance project.
John Tai
Global MBA Candidate, Johns Hopkins Carey Business School
John received his Bachelor in Management Information System from National Sun Yat-Sen University in Taiwan. After working as a marketing specialist in TFT-LCD industry for more than four years, he decided to enter business school to explore better learning of strategy and business development.
Richard Tsai
M.Sc Candidate, Johns Hopkins University
Richard is finishing up his MS degree in biotechnology business enterprise & regulatory affairs. Before coming back to school, Richard garnered various functional experiences from the biotech world, including market analysis at a VC, business development, and also R & D for breast cancer drug development. He is currently involved in site development and promoting awareness for RGI.
Meisha Bynoe, PhD
Microbiology PhD, Yale University
Meisha completed her PhD in Microbiology at Yale University, during which time she was a fellow of the Howard Hughes Medical Institute. Her thesis work involved the examination of how herpesviruses avoid the human immune response. She has also conducted research in various other fields at UCSF, MIT and Singapore's Institute of Bioengineering and Nanotechnology. Meisha holds undergraduate degrees in Biology and Music from MIT.
Marisa Dolled-Filhart, PhD
Genetics PhD, Yale University
Marisa Dolled-Filhart (Ph.D). received a BA in Biology from Cornell University, where she was a Coca Cola National Scholar. She completed her M.Phil. and Ph.D. in Genetics at Yale University, where she was awarded a US Dept. of Defense Breast Cancer Research Fellowship. She has several years of operational and strategy experience from scientific and business development positions at HistoRx (a Yale biotech startup) and Quintiles.
Caryn Kong
BSc in Molecular, Cellular, and Developmental Biology, University of Michigan
Caryn is currently teaching Chemistry and Biology in a high school in Malaysia. She received her BSc in Molecular, Cellular and Developmental Biology from the University of Michigan, Ann Arbor. During her time at UMich, she researched the roles of Drosophila zinc-finger proteins in embryonic development. She was also actively involved in various education and community projects with HIV affected youth in China through the School of Social Work. At RGI, she is involved with the site development in Malaysia and Singapore.
Milap Thaker
MBA Candidate, Johns Hopkins University
Milap is a molecular biologist and vaccine production expert who has worked at AstraZeneca, MIT, and Merck Group, where he tested the prototype Mobius bioreactor for vaccine manufacturing. Prior to Merck, he worked for a VC-funded, acquired biotech startup on a project to deliver RNA interference and helped to meet a $1MM Novartis option fund milestone. He has studied at Harvard and Columbia Universities.
Drew Dunahue
Account Executive, AHM Financial Group, LLC
Drew is a sales and marketing professional with over 10 years of experience networking, cultivating professional relationships and developing new business opportunities. He also volunteers his time and expertise to further the efforts of charitable organizations he supports by fundraising and serving on business development committees. Drew holds a degree in marketing and plans on continuing his education by pursing an MBA.
